Monthly Prescribing Reference

FDA: Dexcom G5 CGM System Can Replace Fingerstick Testing in T2DM Management

The Food and Drug Administration (FDA) has expanded the use of Dexcom's G5 Mobile Continuous Glucose Monitoring (CGM) System to allow for replacement of blood glucose testing for diabetes treatment ...
MobiHealthNews

FDA meeting to weigh whether Dexcom's G5 CGM can replace fingersticks for treatment decisions

Next month the FDA is hosting a public advisory committee meeting to discuss a change to the intended use of Dexcom's G5 Mobile Continuous Glucose Monitoring System (CGM) device that would allow the ...
FierceBiotech

FDA panel docs upbeat ahead of Dexcom panel

Dexcom is looking for the agency to let patients use the device without the confirmation of a finger stick before treatment. The G5 CGM system includes a glucose sensor, a transmitter that sends the ...
Healio

FDA approves DexCom CGM system to replace fingerstick testing

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved an expanded indication for DexCom’s G5 Mobile Continuous Glucose Monitoring System to ...
Healio

FDA advisory panel recommends CGM as replacement for SMBG

Please provide your email address to receive an email when new articles are posted on . An FDA advisory panel recommended a change in intended use for Dexcom’s G5 Mobile Continuous Glucose Monitoring ...
MobiHealthNews

FDA approves Dexcom for Bluetooth-enabled CGM G5

The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...
PR Newswire

Dexcom G5® Mobile Continuous Glucose Monitoring System Receives CE Mark

First and only mobile-connected CGM with no confirmatory finger sticks needed for treatment decisions* for adults and children as young as 2 years of age. The new system is the first mobile-connected ...